Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-14

Clinical Trial Update: Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining abuse liability of reduced nicotine content cigarettes when used concurrently with electronic cigarettes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Nicotine Addiction, Cigarette Smoking | Phase 2 | Status: COMPLETED